Jonas Blaes

2.1k total citations
14 papers, 434 citations indexed

About

Jonas Blaes is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Jonas Blaes has authored 14 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 3 papers in Immunology. Recurrent topics in Jonas Blaes's work include Glioma Diagnosis and Treatment (7 papers), Microscopic Colitis (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). Jonas Blaes is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Microscopic Colitis (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). Jonas Blaes collaborates with scholars based in Germany, United States and Switzerland. Jonas Blaes's co-authors include Wolfgang Wick, Markus Weiler, Michael Platten, Frank Winkler, Leonie Jestaedt, Martin Bendszus, Matthias Osswald, Andreas von Deimling, Felix Sahm and Yunxiang Liao and has published in prestigious journals such as Oncogene, Clinical Cancer Research and Cell stem cell.

In The Last Decade

Jonas Blaes

14 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonas Blaes Germany	9	192	143	128	95	87	14	434
Matthew Genet United States	12	240 1.3×	92 0.6×	133 1.0×	100 1.1×	95 1.1×	20	498
Alicia Lenzen United States	7	183 1.0×	84 0.6×	133 1.0×	77 0.8×	75 0.9×	25	437
Diane D. Mao United States	11	242 1.3×	128 0.9×	150 1.2×	104 1.1×	46 0.5×	16	482
David Dadey United States	11	358 1.9×	64 0.4×	103 0.8×	76 0.8×	55 0.6×	21	661
Kimberly Ng United States	9	261 1.4×	187 1.3×	108 0.8×	154 1.6×	70 0.8×	19	483
Leire Moreno‐Cugnon Spain	12	311 1.6×	140 1.0×	86 0.7×	193 2.0×	41 0.5×	17	557
Seamus P. Caragher United States	9	172 0.9×	189 1.3×	89 0.7×	78 0.8×	47 0.5×	13	376
Uday Bhanu Maachani United States	13	257 1.3×	149 1.0×	108 0.8×	73 0.8×	45 0.5×	20	533
Carmen Rapp Germany	7	155 0.8×	152 1.1×	102 0.8×	97 1.0×	89 1.0×	11	432
Antonela S. Asad Argentina	12	216 1.1×	125 0.9×	129 1.0×	65 0.7×	40 0.5×	20	451

Countries citing papers authored by Jonas Blaes

Since Specialization

Citations

This map shows the geographic impact of Jonas Blaes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Blaes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Blaes more than expected).

Fields of papers citing papers by Jonas Blaes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Blaes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Blaes. The network helps show where Jonas Blaes may publish in the future.

Co-authorship network of co-authors of Jonas Blaes

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Blaes. A scholar is included among the top collaborators of Jonas Blaes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Blaes. Jonas Blaes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Reppell, Mark, Xiuwen Zheng, Jonas Blaes, et al.. (2024). HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn’s Disease Studies. Journal of Crohn s and Colitis. 19(1). 8 indexed citations

D’Cunha, Ronilda, H. Küpper, Dilek Arikan, et al.. (2023). A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants. British Journal of Clinical Pharmacology. 90(1). 189–199. 6 indexed citations

Bobadilla, Ana Victoria Ponce, Sven Stodtmann, Sven Mensing, et al.. (2023). Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulcerative Colitis. Clinical Pharmacokinetics. 62(4). 623–634. 4 indexed citations

Goodman, Joanne, Jonas Blaes, John Cook, et al.. (2021). A Strategic Approach to Nonclinical Immunogenicity Assessment: A Recommendation from the European Bioanalysis Forum. Bioanalysis. 13(7). 537–549. 12 indexed citations

Osswald, Matthias, Jonas Blaes, Yunxiang Liao, et al.. (2016). Impact of Blood–Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases. Clinical Cancer Research. 22(24). 6078–6087. 88 indexed citations

Thomé, Carina M., Jonas Blaes, Jana K. Sonner, et al.. (2016). OS1.3 N-Myc downstream regulated gene 1 (NDRG1) influences the glioma tumor microenvironment. Neuro-Oncology. 18(suppl_4). iv2–iv3. 1 indexed citations

Lemke, Dieter, Markus Zorn, Manfred Jugold, et al.. (2016). Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy. Oncotarget. 7(35). 56713–56725. 33 indexed citations

Osswald, Matthias, Erik Jung, Sophie Weil, et al.. (2016). P08.31 A perivascular niche for progression and resistance in glioblastoma. Neuro-Oncology. 18(suppl_4). iv48–iv48. 1 indexed citations

Broggini, Thomas, Christoph Harms, Jonas Blaes, et al.. (2015). NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment. Cancer Letters. 380(2). 568–576. 16 indexed citations

10.

Keßler, Tobias, Felix Sahm, Jonas Blaes, et al.. (2015). Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma. Oncotarget. 6(31). 31050–31068. 45 indexed citations

11.

Zhu, Zhe, Muhammad Amir Khan, Markus Weiler, et al.. (2014). Targeting Self-Renewal in High-Grade Brain Tumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival. Cell stem cell. 15(2). 185–198. 91 indexed citations

12.

Ott, Martina, Ulrike Litzenburger, Katharina J. Rauschenbach, et al.. (2014). Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. Glia. 63(1). 78–90. 55 indexed citations

13.

Lemke, Dieter, Markus Weiler, Jonas Blaes, et al.. (2014). Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?. Journal of Neurochemistry. 131(2). 251–264. 41 indexed citations

14.

Weiler, Markus, Jonas Blaes, Leonie Jestaedt, et al.. (2012). Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment. Oncogene. 32(9). 1099–1109. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact